Bulletin
Cure Worse than Disease
In his critique of the current free-market model for funding pharmaceutical research "Bad Rx - Big Pharma & Medical Research" (commentary, Bulletin, Oct. 2003), ethics professor Arthur Schafer argues that, "if biomedical researchers and their universities are to retain public […]
02-11-2003